{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:42:15Z","timestamp":1790739735718,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>\n                    Hepatosplenic T-cell lymphoma (HSTCL) is a rare type of lymphoma. Patients have a poor prognosis, and there is no standard of care. We evaluated 28 HSTCL patients to determine factors that may be associated with outcome. There were 19 men and 9 women with a median age of 32.5 years. Most patients had massive splenomegaly, and bone marrow showed sinusoidal involvement by lymphoma. The HSTCL cells expressed \u03b3\u03b4 T-cell receptor (TCR) in 20 (74%), \u03b1\u03b2 TCR in 5 (19%), and neither in 2 (7%) patients (1 case not assessed). Conventional cytogenetics and\/or fluorescence in situ hybridization analysis in 24 patients at diagnosis showed isochromosome 7q (i7q) in 10 (42%) and trisomy 8 in 8 (33%) patients. Median overall survival (OS) and event-free survival (EFS) were each 28.3 months. Serum bilirubin level \u22651.5 mg\/dL, \u03b1\u03b2 TCR expression, and trisomy 8 each correlated significantly with shorter OS and EFS. Patients with HSTCL received a variety of chemotherapy regimens with no regimen better than any other. However, patients who underwent stem cell transplant showed longer survival (OS: hazard ratio 0.3,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.09; EFS: hazard ratio 0.2,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.034). In conclusion, although HSTCL patients have a poor prognosis overall, the data presented support the novel suggestions that HSTCL patients can be stratified into 2 prognostic groups, with an elevated serum bilirubin level, \u03b1\u03b2 TCR expression, and trisomy 8 identifying a poorer prognostic group. In addition, the outcomes of this patient cohort suggest that stem cell transplantation has value for the treatment of patients with HSTCL.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000000614","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T09:07:18Z","timestamp":1455268038000},"page":"676-688","source":"Crossref","is-referenced-by-count":81,"title":["Prognostic Factors of Hepatosplenic T-cell Lymphoma"],"prefix":"10.1097","volume":"40","author":[{"given":"Mariko","family":"Yabe","sequence":"first","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago","family":"Nieto","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Oki","sequence":"additional","affiliation":[{"name":"Lymphoma\/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Routbort","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajyalakshmi","family":"Luthra","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Fanale","sequence":"additional","affiliation":[{"name":"Lymphoma\/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hoehn","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergej","family":"Konoplev","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denai R.","family":"Milton","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Wistuba","sequence":"additional","affiliation":[{"name":"Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. James","family":"You","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1309\/TC9U-FAV7-0QBW-6DFC","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature","volume":"116","author":"Khan","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R5-20230922","first-page":"109","article-title":"Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant","volume":"11","author":"Chalmers","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1309\/AJCPJSA1E1YWSZEY","article-title":"Clinicopathologic, immunophenotypic, cytogenetic, and molecular features of gamma delta T-cell large granular lymphocytic leukemia: an analysis of 14 patients suggests biologic differences with alpha beta T-cell large granular lymphocytic leukemia","volume":"144","author":"Yabe","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V99.1.268","article-title":"Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B","volume":"99","author":"Morice","year":"2002","journal-title":"Blood"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/modpathol.3800145","article-title":"Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma","volume":"17","author":"Admirand","year":"2004","journal-title":"Mod Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.humpath.2003.10.013","article-title":"Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria","volume":"35","author":"Herling","year":"2004","journal-title":"Hum Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/modpathol.2009.175","article-title":"Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sezary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging","volume":"23","author":"Feng","year":"2010","journal-title":"Mod Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/JQMR-323G-71Y9-M7MB","article-title":"Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities","volume":"116","author":"Onciu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1309\/5WFQ-N12E-DT05-UX1T","article-title":"A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/modpathol.2013.122","article-title":"Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics","volume":"27","author":"Kanagal-Shamanna","year":"2014","journal-title":"Mod Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12032-009-9292-y","article-title":"Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia","volume":"27","author":"Norin","year":"2010","journal-title":"Med Oncol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.sla.0000080826.97026.d8","article-title":"Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy","volume":"238","author":"Patel","year":"2003","journal-title":"Ann Surg"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11912-008-0062-3","article-title":"Novel therapies in peripheral T-cell lymphomas","volume":"10","author":"O\u2019Leary","year":"2008","journal-title":"Curr Oncol Rep"},{"issue":"suppl 1","key":"R20-20230922","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1053\/j.seminhematol.2010.01.014","article-title":"Novel agents in development for peripheral T-cell lymphoma","volume":"47","author":"O\u2019Connor","year":"2010","journal-title":"Semin Hematol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/era.11.4","article-title":"New drug therapies in peripheral T-cell lymphoma","volume":"11","author":"Howman","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOH.0b013e32832ad69a","article-title":"Novel therapies for peripheral T-cell non-Hodgkin\u2019s lymphomas","volume":"16","author":"Cheson","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic T gamma\/delta lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R29-20230922","first-page":"612","article-title":"Mutations of FBXW7 in adult T-cell acute lymphocytic leukemia","volume":"23","author":"Guo","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature14430","article-title":"Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment","volume":"523","author":"Alexandrova","year":"2015","journal-title":"Nature"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: multiple functions in human malignant tumors","volume":"5","author":"Milella","year":"2015","journal-title":"Front Oncol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"R34-20230922","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2015.11.010","article-title":"Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients","author":"Yabe","year":"2016","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201605000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:22:48Z","timestamp":1695406968000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201605000-00012"}},"subtitle":["Clinicopathologic Study of 28 Cases"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000614","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}